Walter-Croneck A - Search Results

1

Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.

Grzasko N, Hus M, Pluta A, Jurczyszyn A, Walter-Croneck A, Morawska M, Chocholska S, Hajek R, Dmoszynska A. Grzasko N, et al. Hematol Oncol. 2013 Mar;31(1):41-8. doi: 10.1002/hon.2018. Epub 2012 Jun 6. Hematol Oncol. 2013. PMID: 22674819

2

Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets.

Dmoszyńska A, Walter-Croneck A, Ledwozyw A. Dmoszyńska A, et al. Thromb Res. 1995 Sep 15;79(5-6):483-90. doi: 10.1016/0049-3848(95)00138-h. Thromb Res. 1995. PMID: 7502274

3

Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.

Dmoszyńska A, Janicki K, Janicka L, Przesmycki K, Sokołowska B, Walter-Croneck A. Dmoszyńska A, et al. Pol J Pharmacol. 1996 May-Jun;48(3):327-9. Pol J Pharmacol. 1996. PMID: 9112671

4

Indobufen induced modification of phospholipid composition in diabetic platelets.

Dmoszyńska A, Sokołowska B, Walter-Croneck A, Przesmycki K, Ledwozyw A. Dmoszyńska A, et al. Pol J Pharmacol. 1996 May-Jun;48(3):331-4. Pol J Pharmacol. 1996. PMID: 9112672

5

[The influence of verapamil on platelet function in patients with multiple myeloma].

Sokołowska B, Dmoszyńska A, Walter-Croneck A, Wojtaszko M. Sokołowska B, et al. Pol Merkur Lekarski. 1997 Feb;2(8):109-10. Pol Merkur Lekarski. 1997. PMID: 9538652 Polish.

6

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

Dmoszyńska A, Roliński J, Bojarska-Junak A, Mańko J, Jawniak D, Walter-Croneck A, Soroka-Wojtaszko M, Hus M. Dmoszyńska A, et al. Pol J Pharmacol. 2001 Nov-Dec;53(6):709-13. Pol J Pharmacol. 2001. PMID: 11985351 Free article.

7

Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.

Zdzisińska B, Walter-Croneck A, Dmoszyńska A, Kandefer-Szerszeń M. Zdzisińska B, et al. Arch Immunol Ther Exp (Warsz). 2006 Jul-Aug;54(4):289-96. doi: 10.1007/s00005-006-0033-z. Epub 2006 Jul 25. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16868721 Free article.

8

The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.

Dmoszynska A, Walter-Croneck A, Hus I, Grzasko N, Manko J, Jedrzejczak WW, Charlinski G, Usnarska-Zubkiewicz L, Skotnicki A, Wolska-Smolen T, Piszcz J, Kloczko J. Dmoszynska A, et al. Leuk Res. 2010 Oct;34(10):1330-5. doi: 10.1016/j.leukres.2010.05.003. Epub 2010 Jun 2. Leuk Res. 2010. PMID: 20627385

9

Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.

Wach M, Cioch M, Hus M, Jawniak D, Legiec W, Malek M, Manko J, Walter-Croneck A, Wasik-Szczepanek E, Dmoszynska A. Wach M, et al. Folia Histochem Cytobiol. 2011;49(2):248-54. doi: 10.5603/fhc.2011.0034. Folia Histochem Cytobiol. 2011. PMID: 21744324 Free article.

10

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.

Sokołowska B, Nowaczyńska A, Bykowska K, Chocholska S, Wejksza K, Walter-Croneck A, Gromek T, Kowalska AM, Kandefer-Szerszeń M, Dmoszyńska A. Sokołowska B, et al. Folia Histochem Cytobiol. 2011;49(2):267-71. doi: 10.5603/fhc.2011.0037. Folia Histochem Cytobiol. 2011. PMID: 21744327 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters